Circulating Biomarkers

Thrombosis Research

Volumn 130, Issue SUPPL.1, 2012, Pages

  Badimon, L ^a,b,c   Romero, J C ^a   Cubedo, J ^a   Borrell Pages M ^a  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

atherosclerosis; biomarker; cardiovascular disease; myocardial infarction; risk factor

Indexed keywords

ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; CLUSTERIN; COPEPTIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; ISCHEMIA MODIFIED ALBUMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; NEUROHORMONE; OSTEOPONTIN; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; SECRETORY PHOSPHOLIPASE A2; TROPONIN; TROPONIN I; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIGH RISK POPULATION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROGNOSIS;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION MEDIATORS; MYOCARDIUM; NECROSIS; NEUROTRANSMITTER AGENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 84866978409     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.08.262     Document Type: Article

References (38)

1. E. Straface, P. Lista, L. Gambardella, F. Franconid, and W. Malorni Gender-specific features of plasmatic and circulating cell alterations as risk factors in cardiovascular disease Fundam Clin Pharmacol 24 2010 665 674
2. T. Wang New cardiovascular risk factors exist, but are they clinically useful? Eur Heart J 29 2008 441 444
3. Biomarkers Definitions Working Group Biomarkers and surrogate end-points: preferred definitions and conceptuals framework Clin Pharmacol Ther 69 2001 89 95
4. R.S. Vasan Biomarkers of cardiovascular disease Circulation 113 2006 2335 2362
5. M. Mathew, and E. Tay Cusi. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects Cardiovasc Diabetol 9 2010 1 9
6. P. André, L. Nannizzi-Alaimo, S.K. Prasad, and D.R. Phillips Platelet-derived CD40L: the switch-hitting player of cardiovascular disease Circulation 106 2002 896 899
7. S. Blankenberg, L. Tiret, C. Bickel, D. Peetz, F. Cambien, and J. Meyer Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina Circulation 106 2002 24 30
8. J.A. de Lemos, D.A. Morrow, M.S. Sabatine, S.A. Murphy, C.M. Gibson, and E.M. Antman Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes Circulation 107 2003 690 695
9. M.W. Mosesson Fibrinogen and fibrin structure and functions J Thromb Haemost 3 2005 1894 1904
10. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, and A. Rumley C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
11. B. Molins, E. Peña, G. Vilahur, C. Mendieta, M. Slevin, and L. Badimon C-reactive protein isoforms differ in their effects on thrombus growth Arterioscler Thromb Vasc Biol 28 12 Dec. 2008 2239 2246
12. S. Nicholls, and S. Hazen Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 2005 1102 1111
13. A.K. Thukkani, J. McHowat, F.F. Hsu, M.L. Brennan, and S.L. Hazen DA F. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions Circulation 108 2003 3128 3133
14. A.T. Askari, M.L. Brennan, X. Zhou, J. Drinko, J. Thomas, E. Topol, S. Hazen, and M. Penn Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction J Exp Med 197 5 2003 615
15. R. Zhang, M.L. Brennan, X. Fu, R.J. Aviles, G.L. Pearce, M.S. Penn, E.J. Topol, D.L. Sprecher, and S.L. Hazen Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2001 2136 2142
16. D. Kutter, P. Devaquet, G. Vanderstocken, J.M. Paulus, V. Marchal, and A. Gothot Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 104 2000 10 15
17. D.V.P. de Kleijn, F.L. Moll, W.E. Hellings, G. Ozsarlak-Sozer, P. de Bruin, and P.A. Doevendans Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events Arterioscler Thromb Vasc Biol 30 2010 [00-00]
18. S.E. Shoelson Inflammation and insulin resistance J Clin Invest 116 7 2006 1793
19. P.E. Pool The clinical significance of neurohormonal activacion Clin Ther 19 1997 53 73
20. D.S. Ang, C.F. Kong, M.P. Kao, and A.D. Struthers Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities Am Heart J 158 2009 133 140
21. M.R. Cowie, A.D. Struthers, D.A. Wood, A.J. Coats, S.G. Thompson, and P.A. Poole-Wilson Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
22. J.P. Hinson, S. Kapas, and D.M. Smith Adrenomedullin, a multifunctional regulatory peptide Endocr Rev 21 2000 138 167
23. K. Takahashi, F. Satoh, E. Hara, M. Sone, O. Murakami, T. Kayama, T. Yoshimoto, and S. Shibahara Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production Peptides 18 1997 1117 1124
24. W. Hochholzer, D.A. Morrow, and R.P. Giugliano Novel biomarkers in cardiovascular disease: Update 2010 Am Heart J 160 2010 583 594
25. S.Q. Khan, O.S. Dhillon, R.J. O'Brien, J. Struck, P.A. Quinn, N.G. Morgenthaler, I.B. Squire, J.E. Davies, A. Bergmann, and L.L. Ng C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study Circulation 115 2007 2103 2110
26. D. Chan, and L.L. Ng Biomarkers in acute myocardial infarction BMC Med 8 2010 34 44
27. D.A. Morrow, J.A. de Lemos, M.S. Sabatine, and E.M. Antman The search for a biomarker of cardiac ischemia Clin Chem 49 4 2003 537 539
28. A.M. Kleinfeld, D. Prothro, D.L. Brown, R.C. Davis, G.V. Richieri, and A. DeMaria Increases in serum unbound free fatty acid levels following coronary angioplasty Am J Cardiol 78 12 1996 1350 1354
29. M. Panteghini Role and importance of biochemical markers in clinical cardiology Eur Heart J 25 14 2004 1187 1196
30. D. Bar-Or, E. Lau, and J.V. Winkler A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report J Emerg Med 19 4 2000 311 315
31. F.S. Apple, H.E. Quist, A.P. Otto, W.E. Mathews, and M.M. Murakami Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race Clin Chem 48 7 2002 1097 1100
32. J. Cubedo, T. Padro, X. García-Moll, X. Pintó, J. Cinca, and L. Badimon Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction J Proteome Res 10 1 2011 211 220
33. M. Emdin, S. Vittorini, C. Passino, and A. Clerico Old and new biomarkers of heart failure Eur J Heart Fail 11 2009 331 335
34. P.O. Collinson, and D.C. Gaze Biomarkers of cardiovascular damage Med Princ Pract 16 2007 247 261
35. O. Melander, C. Newton-Cheh, P. Almgren, B. Hedblad, G. Berglund, and G. Engström Novel and conventional biomarkers for prediction of incident cardiovascular events in the community J Am Med Assoc 302 2009 49 57
36. G.D. Smith, and S. Ebrahim Mendelian randomization: prospects, potentials and limitations Int J Epidemiol 33 1 2004 30 42
37. M. Siervo, D. Ruggiero, R. Sorice, T. Nutile, M. Aversano, B.C.M. Stephan, and M. Ciullo Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome J Intern Med 268 2010 338 347
38. J.S. Rana, B.J. Arsenault, J.P. Després, M. Côté, P.J. Talmud, and E. Ninio Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthymen and women Eur Heart J 32 2011 336 344